Skip to main content
. 2020 Jun 16;11:1220. doi: 10.3389/fmicb.2020.01220

TABLE 3.

Anti-PGL-I IgM positivity.

Genotype Number of positive individual % of positivity
MB patients BI 2-6 (n = 33) 33 100.0
Patients BI 0 (n = 27) 9 33.3
Healthy household contacts (n = 250) 9 36.8

Anti-PGL-I antibody levels were measured by up-converting phosphor lateral flow assay specific for M. leprae PGL-I IgM antibodies (UCP-LFA) using the Ratio (R) of the Test (T) and flow control (FC) lines as units. Ratios of ≥0.10 were considered positive.